ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 135 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,540 | -49.8% | 293,766 | -11.8% | 0.07% | -48.9% |
| Q2 2021 | $7,045 | -20.5% | 333,085 | +5.4% | 0.13% | -30.3% |
| Q1 2021 | $8,862 | -24.3% | 315,920 | -29.9% | 0.19% | -28.5% |
| Q4 2020 | $11,710 | -35.5% | 450,398 | -7.7% | 0.26% | -57.3% |
| Q3 2020 | $18,143 | +13.4% | 488,099 | +56.6% | 0.62% | +6.6% |
| Q2 2020 | $15,997 | +120.2% | 311,776 | +35.3% | 0.58% | +47.8% |
| Q1 2020 | $7,266 | -57.3% | 230,454 | -19.2% | 0.39% | -50.1% |
| Q4 2019 | $17,014 | +200.1% | 285,327 | +84.5% | 0.78% | +151.0% |
| Q3 2019 | $5,669 | +13.9% | 154,628 | +42.9% | 0.31% | -11.4% |
| Q4 2018 | $4,977 | +0.6% | 108,200 | -2.9% | 0.35% | +31.3% |
| Q3 2018 | $4,945 | +17.5% | 111,450 | +3.8% | 0.27% | +5.9% |
| Q2 2018 | $4,207 | +35.5% | 107,350 | -56.7% | 0.25% | +136.4% |
| Q4 2016 | $3,105 | -9.6% | 248,030 | 0.0% | 0.11% | -4.5% |
| Q3 2016 | $3,435 | +40.1% | 248,030 | 0.0% | 0.11% | +25.8% |
| Q2 2016 | $2,451 | -41.5% | 248,030 | +0.2% | 0.09% | -41.4% |
| Q1 2016 | $4,187 | -24.0% | 247,630 | 0.0% | 0.15% | -20.0% |
| Q4 2015 | $5,512 | -22.0% | 247,630 | -17.3% | 0.19% | -13.2% |
| Q3 2015 | $7,067 | -67.9% | 299,580 | +11.1% | 0.22% | -64.9% |
| Q2 2015 | $22,041 | +2.3% | 269,580 | +15.8% | 0.62% | +1.1% |
| Q1 2015 | $21,555 | – | 232,780 | – | 0.62% | – |
Download | ||||||